2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC4557 | |||||||||||||||||||||||
Submitter : | Ms. Mary Davis | Date & Time: | 02/22/2006 02:02:44 | |||||||||||||||||||||
Organization : | Private Citizen | |||||||||||||||||||||||
Category : | Drug Industry | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
I am deeply concerned that my access to safe and efficacious bio-identical hormone replacement therapies (BHRT) could be at risk. Even more, I am horrified that Wyeth would so brazenly attempt to use its corporate wealth and power to twist the facts, manipulate the research and, ultimately, push their mercenary agenda through a federal governing body . . . | ||||||||||||||||||||||||